DUVELISIB for Follicular lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 28 adverse event reports in the FDA FAERS database where DUVELISIB was used for Follicular lymphoma.
Most Reported Side Effects for DUVELISIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Product use in unapproved indication | 162 | 21.4% | 32 | 54 |
| Diarrhoea | 110 | 14.5% | 8 | 47 |
| Death | 89 | 11.8% | 87 | 13 |
| Fatigue | 75 | 9.9% | 5 | 24 |
| Prescribed underdose | 63 | 8.3% | 8 | 18 |
| Off label use | 57 | 7.5% | 4 | 8 |
| Nausea | 49 | 6.5% | 6 | 20 |
| Pneumonia | 40 | 5.3% | 15 | 27 |
| Pyrexia | 40 | 5.3% | 3 | 21 |
| Malignant neoplasm progression | 38 | 5.0% | 15 | 20 |
| Rash | 33 | 4.4% | 2 | 8 |
| Hospitalisation | 32 | 4.2% | 4 | 30 |
| Asthenia | 30 | 4.0% | 1 | 13 |
| Vomiting | 30 | 4.0% | 5 | 20 |
| Disease progression | 28 | 3.7% | 15 | 11 |
Other Indications for DUVELISIB
Chronic lymphocytic leukaemia (156)
Peripheral t-cell lymphoma unspecified (111)
B-cell lymphoma (87)
Non-hodgkin's lymphoma (59)
Angioimmunoblastic t-cell lymphoma (54)
Product used for unknown indication (38)
Cutaneous t-cell lymphoma (37)
T-cell lymphoma (18)
Lymphocytic leukaemia (14)
B-cell small lymphocytic lymphoma (12)
Other Drugs Used for Follicular lymphoma
LENALIDOMIDE (3,611)
RITUXIMAB (3,294)
OBINUTUZUMAB (2,527)
BENDAMUSTINE (1,560)
CYCLOPHOSPHAMIDE (1,367)
VINCRISTINE (1,224)
DOXORUBICIN (1,115)
PREDNISONE (889)
TAZEMETOSTAT HYDROBROMIDE (439)
ETOPOSIDE (352)